Kristine Rose

2.8k total citations · 1 hit paper
23 papers, 1.4k citations indexed

About

Kristine Rose is a scholar working on Molecular Biology, Gastroenterology and Oncology. According to data from OpenAlex, Kristine Rose has authored 23 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Gastroenterology and 5 papers in Oncology. Recurrent topics in Kristine Rose's work include Gastrointestinal motility and disorders (7 papers), Advanced Breast Cancer Therapies (3 papers) and Hedgehog Signaling Pathway Studies (3 papers). Kristine Rose is often cited by papers focused on Gastrointestinal motility and disorders (7 papers), Advanced Breast Cancer Therapies (3 papers) and Hedgehog Signaling Pathway Studies (3 papers). Kristine Rose collaborates with scholars based in United States, United Kingdom and Switzerland. Kristine Rose's co-authors include JoAnne Engebrecht, Simon A. Rudge, Michael A. Frohman, Andrew J. Morris, Scott M. Hammond, Yelena M. Altshuller, W. H. Percy, P. Bentley, Robyn L. Fisher and Alison E.M. Vickers and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Blood.

In The Last Decade

Kristine Rose

22 papers receiving 1.4k citations

Hit Papers

Human ADP-ribosylation Factor-activated Phosphatidylcholi... 1995 2026 2005 2015 1995 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kristine Rose United States 14 971 331 172 155 144 23 1.4k
Jun Ishizaki Japan 21 1.1k 1.1× 256 0.8× 208 1.2× 171 1.1× 72 0.5× 49 1.9k
Masataka Kohno Japan 22 1.2k 1.2× 151 0.5× 250 1.5× 187 1.2× 115 0.8× 79 2.3k
Shairaz Baksh Canada 25 1.3k 1.3× 544 1.6× 204 1.2× 132 0.9× 74 0.5× 39 1.9k
Sara Martínez‐Martínez Spain 25 1.3k 1.4× 144 0.4× 343 2.0× 114 0.7× 87 0.6× 36 2.2k
Ming‐Chei Maa Taiwan 22 956 1.0× 230 0.7× 378 2.2× 96 0.6× 63 0.4× 35 1.6k
Francesca Buricchi Italy 20 1.0k 1.1× 283 0.9× 154 0.9× 164 1.1× 44 0.3× 32 1.7k
Katarzyna Augoff Poland 19 1.0k 1.1× 190 0.6× 299 1.7× 91 0.6× 61 0.4× 35 1.7k
Ju-Ming Wang Taiwan 28 1.3k 1.3× 147 0.4× 414 2.4× 102 0.7× 98 0.7× 44 2.1k

Countries citing papers authored by Kristine Rose

Since Specialization
Citations

This map shows the geographic impact of Kristine Rose's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kristine Rose with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kristine Rose more than expected).

Fields of papers citing papers by Kristine Rose

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kristine Rose. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kristine Rose. The network helps show where Kristine Rose may publish in the future.

Co-authorship network of co-authors of Kristine Rose

This figure shows the co-authorship network connecting the top 25 collaborators of Kristine Rose. A scholar is included among the top collaborators of Kristine Rose based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kristine Rose. Kristine Rose is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
O’Brien, Neil A., Martina S.J. McDermott, Dylan Conklin, et al.. (2020). Targeting activated PI3K/mTOR signaling overcomes acquired resistance to CDK4/6-based therapies in preclinical models of hormone receptor-positive breast cancer. Breast Cancer Research. 22(1). 89–89. 87 indexed citations
2.
Jayaraman, Pushpa, John M. Millholland, Neil A. O’Brien, et al.. (2019). Abstract C103: Targeting IL-1β pathway for cancer immunotherapy. Molecular Cancer Therapeutics. 18(12_Supplement). C103–C103. 3 indexed citations
3.
O’Brien, Neil A., Dylan Conklin, Alex Gaither, et al.. (2019). Abstract 3825: Targeting activated PI3K/mTOR signaling overcomes resistance to CDK4/6-based therapies in preclinical ER+ breast cancer models. 3825–3825. 1 indexed citations
4.
O’Brien, Neil A., Martina S.J. McDermott, Dylan Conklin, et al.. (2019). Abstract 3825: Targeting activated PI3K/mTOR signaling overcomes resistance to CDK4/6-based therapies in preclinical ER+ breast cancer models. Cancer Research. 79(13_Supplement). 3825–3825. 1 indexed citations
5.
Rodón, Jordi, Hussein Tawbi, Anne Thomas, et al.. (2014). A Phase I, Multicenter, Open-Label, First-in-Human, Dose-Escalation Study of the Oral Smoothened Inhibitor Sonidegib (LDE225) in Patients with Advanced Solid Tumors. Clinical Cancer Research. 20(7). 1900–1909. 187 indexed citations
6.
Bhagwat, Neha, Matthew D. Keller, Raajit K. Rampal, et al.. (2013). Improved Efficacy Of Combination Of JAK2 and Hedgehog Inhibitors In Myelofibrosis. Blood. 122(21). 666–666. 47 indexed citations
7.
Amakye, Dereck D., Douglas Robinson, Kristine Rose, et al.. (2012). Abstract 4818: The predictive value of a 5-gene signature as a patient pre-selection tool in medulloblastoma for Hedgehog pathway inhibitor therapy. Cancer Research. 72(8_Supplement). 4818–4818. 9 indexed citations
8.
Serebruany, Victor L., et al.. (2010). Investigations on 5-HT4 Receptor Expression and Effects of Tegaserod on Human Platelet Aggregation In Vitro. American Journal of Therapeutics. 17(6). 543–552. 17 indexed citations
10.
Vickers, Alison E.M., Kristine Rose, Robyn L. Fisher, et al.. (2004). Kidney Slices of Human and Rat to Characterize Cisplatin-Induced Injury on Cellular Pathways and Morphology. Toxicologic Pathology. 32(5). 577–590. 120 indexed citations
12.
Engebrecht, JoAnne, et al.. (1998). Yeast Meiotic Mutants Proficient for the Induction of Ectopic Recombination. Genetics. 148(2). 581–598. 25 indexed citations
13.
Percy, W. H., et al.. (1998). In vitro evidence that rabbit distal colonic muscularis mucosae has aClostridium difficiletoxin A receptor. American Journal of Physiology-Gastrointestinal and Liver Physiology. 275(3). G402–G409. 5 indexed citations
14.
Hammond, Scott M., Yelena M. Altshuller, Simon A. Rudge, et al.. (1995). Human ADP-ribosylation Factor-activated Phosphatidylcholine-specific Phospholipase D Defines a New and Highly Conserved Gene Family. Journal of Biological Chemistry. 270(50). 29640–29643. 586 indexed citations breakdown →
15.
Burakoff, Robert, Lee C. Zhao, Kristine Rose, et al.. (1995). Effects of purified Clostridium difficile toxin A on rabbit distal colon. Gastroenterology. 109(2). 348–354. 26 indexed citations
16.
Rose, Kristine, Simon A. Rudge, Michael A. Frohman, Andrew J. Morris, & JoAnne Engebrecht. (1995). Phospholipase D signaling is essential for meiosis.. Proceedings of the National Academy of Sciences. 92(26). 12151–12155. 189 indexed citations
17.
Percy, W. H., et al.. (1993). In vitro changes in the properties of rabbit colonie muscularis mucosae in colitis. Gastroenterology. 104(2). 369–376. 35 indexed citations
18.
Goldhill, J, R. Burakoff, Virginia Donovan, Kristine Rose, & W. H. Percy. (1993). Defective modulation of colonic secretomotor neurons in a rabbit model of colitis. American Journal of Physiology-Gastrointestinal and Liver Physiology. 264(4). G671–G677. 25 indexed citations
19.
Percy, W. H., et al.. (1993). Pharmacological basis of contractile effects of peptidoleukotrienes on rabbit colonic muscularis mucosae. American Journal of Physiology-Gastrointestinal and Liver Physiology. 264(1). G81–G85. 12 indexed citations
20.
Percy, W. H., et al.. (1992). Pharmacologic characterization of the muscularis mucosae in three regions of the rabbit colon.. Journal of Pharmacology and Experimental Therapeutics. 261(3). 1136–1142. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026